Nutrien (NYSE:NTR) Upgraded by Piper Sandler to “Overweight” Rating

Nutrien (NYSE:NTRGet Free Report) was upgraded by investment analysts at Piper Sandler from an “underweight” rating to an “overweight” rating in a research note issued on Monday. The firm currently has a $58.00 target price on the stock, up from their prior target price of $50.00. Piper Sandler’s target price would suggest a potential upside of 19.69% from the stock’s previous close.

Several other equities research analysts have also recently commented on NTR. CIBC reaffirmed an “outperformer” rating and set a $55.00 target price (down previously from $60.00) on shares of Nutrien in a research note on Tuesday, December 10th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $60.00 target price on shares of Nutrien in a research note on Friday, September 20th. Oppenheimer initiated coverage on Nutrien in a research note on Thursday, December 12th. They set an “outperform” rating and a $60.00 target price for the company. Raymond James upgraded Nutrien from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $58.00 to $60.00 in a report on Tuesday, December 3rd. Finally, TD Securities cut their price target on Nutrien from $63.00 to $61.00 and set a “buy” rating on the stock in a report on Tuesday, November 12th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $59.21.

Read Our Latest Analysis on Nutrien

Nutrien Trading Up 1.3 %

Shares of NTR stock opened at $48.46 on Monday. The stock has a 50-day moving average of $46.87 and a 200-day moving average of $47.85. Nutrien has a 1-year low of $43.69 and a 1-year high of $60.87. The stock has a market cap of $23.86 billion, a price-to-earnings ratio of 32.52, a PEG ratio of 1.73 and a beta of 0.81. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38.

Nutrien (NYSE:NTRGet Free Report) last released its earnings results on Wednesday, November 6th. The company reported $0.39 EPS for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business had revenue of $5.35 billion for the quarter, compared to analyst estimates of $5.26 billion. During the same period in the prior year, the business earned $0.35 EPS. The company’s revenue for the quarter was down 5.0% on a year-over-year basis. On average, equities research analysts forecast that Nutrien will post 3.5 earnings per share for the current year.

Institutional Trading of Nutrien

A number of large investors have recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC grew its position in shares of Nutrien by 6.5% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 4,309 shares of the company’s stock valued at $207,000 after purchasing an additional 263 shares in the last quarter. Meixler Investment Management Ltd. grew its position in shares of Nutrien by 4.2% in the third quarter. Meixler Investment Management Ltd. now owns 7,159 shares of the company’s stock valued at $344,000 after purchasing an additional 288 shares in the last quarter. Atria Investments Inc grew its position in shares of Nutrien by 2.0% in the third quarter. Atria Investments Inc now owns 14,636 shares of the company’s stock valued at $703,000 after purchasing an additional 290 shares in the last quarter. Mercer Global Advisors Inc. ADV grew its position in shares of Nutrien by 8.3% in the second quarter. Mercer Global Advisors Inc. ADV now owns 4,660 shares of the company’s stock valued at $237,000 after purchasing an additional 356 shares in the last quarter. Finally, Kingsview Wealth Management LLC grew its position in shares of Nutrien by 3.3% in the third quarter. Kingsview Wealth Management LLC now owns 11,317 shares of the company’s stock valued at $544,000 after purchasing an additional 365 shares in the last quarter. 63.10% of the stock is owned by hedge funds and other institutional investors.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Stories

Analyst Recommendations for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.